To evaluate the diagnostic utility of METTL1 and WDR4 as non-invasive biomarkers for BC detection, we employed Receiver operating characteristic (ROC) curves, and the area under the ROC curve (AUC) was calculated. The gene discussed is METTL1; the disease is breast cancer.